ARTHUR ISSAC LESTER
Allopathic & Osteopathic Physicians|Otolaryngology BELLEVILLE, NJ NPI 1528028347
Browse related groups: Allopathic & Osteopathic Physicians|Otolaryngology NJ Amarin Pharma Inc. All categories
General Payments — all program years on this page
$269.04
- Category: General Payments
- Program years: PY2018–2020
- Record count: 18
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $127.19 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $127.19 | 9 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amarin Pharma Inc. | $43.88 | 3 |
| GlaxoSmithKline, LLC. | $27.96 | 2 |
| ABBVIE INC. | $26.14 | 2 |
| Novo Nordisk AS | $14.98 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.23 | 1 |
By program year
Records — PY2020 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 716759415 | Kowa Pharmaceuticals America, Inc. | $14.23 | 05/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 721986787 | AbbVie Inc. | $13.63 | 07/31/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 721986791 | AbbVie Inc. | $12.51 | 09/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 738529085 | GlaxoSmithKline, LLC. | $12.46 | 07/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 738642999 | GlaxoSmithKline, LLC. | $15.50 | 09/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 739799227 | Amarin Pharma Inc. | $14.86 | 06/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 739799233 | Amarin Pharma Inc. | $14.16 | 07/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 739805907 | Amarin Pharma Inc. | $14.86 | 06/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 745155745 | Novo Nordisk Inc | $14.98 | 09/29/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.